TLDR

Diabetic foot ulcers classified as Wagner Grade III or higher qualify for FDA-approved, Medicare-covered hyperbaric oxygen therapy (HBOT) when standard wound care has failed for 30+ days. HBOT delivers 100% medical-grade oxygen under pressure up to 2.4 ATA, dissolving oxygen directly into plasma to reach hypoxic, non-healing tissue. Clinical evidence shows HBOT produces up to 4x higher healing rates for diabetic wounds compared to standard care alone. OxygenWell in Sherman Oaks and Calabasas, CA is a physician-owned, Medicare-approved HBOT facility offering personalized wound care protocols supervised by hyperbaric medicine specialists.

Table of Contents

• What Is a Wagner Grade III Diabetic Foot Ulcer?
• Why Standard Wound Care Fails
• How HBOT Heals Diabetic Wounds
• Clinical Evidence: What the Research Shows
• Medicare Coverage for HBOT: What You Need to Qualify
• What to Expect: HBOT Treatment Protocol
• Diabetic Wound Care in Los Angeles: Why OxygenWell
• Frequently Asked Questions

Introduction

A diabetic foot ulcer does not start as a crisis. It starts as a blister, a callus, a small break in the skin that a healthy person would not give a second thought. For someone living with diabetes, that same wound can spiral — slowly at first, then rapidly — into a non-healing ulcer that resists weeks of dressings, debridement, and antibiotics.

The hard truth: nearly 15–25% of people with diabetes will develop a foot ulcer during their lifetime. Diabetic foot ulcers account for more than 60% of all non-traumatic lower-extremity amputations in the United States. When standard wound care stalls, the question is no longer whether to escalate treatment — it is how fast.

Hyperbaric oxygen therapy for diabetic foot ulcers is not experimental. It is an FDA-recognized, Medicare-covered treatment for qualifying patients. At OxygenWell, our hyperbaric medicine team has supervised more than 50,000 HBOT sessions and coordinates all insurance pre-authorization so patients can access this therapy without delay.

What Is a Wagner Grade III Diabetic Foot Ulcer?

The Wagner Classification System is the standard used by Medicare and most insurers to assess diabetic foot wound severity. It grades ulcers from 0 to 5:

GradeDescription 0Pre-ulceration or healed ulcer; intact skin 1Superficial ulcer; no subcutaneous involvement 2Deep ulcer to tendon, capsule, or bone without infection 3Deep ulcer with osteomyelitis, joint infection, or deep abscess 4Gangrene of the forefoot or heel 5Gangrene of the entire foot

Wagner Grade III is the threshold at which diabetic foot ulcers become eligible for Medicare-covered HBOT. At this stage, the ulcer has penetrated to bone or joint structures and typically involves active infection (osteomyelitis or deep abscess). The tissue is profoundly hypoxic. Standard wound care alone rarely achieves measurable closure.

Grades IV and V — where gangrene has set in — also qualify and represent even greater urgency. The window for salvaging the limb narrows with every week of inadequate healing.

Why Standard Wound Care Fails

Standard wound care — off-loading, debridement, moisture-retentive dressings, antibiotics, blood sugar control — forms the necessary foundation. But for Grade III+ ulcers, it often cannot do the job alone. Three physiological failures explain why.

1. Diabetic Microangiopathy

Chronic elevated blood glucose damages small blood vessels throughout the body. In the feet, this means capillary walls thicken, blood flow slows, and the tissue at the wound bed receives a fraction of the oxygen it needs to generate new cells and fight infection. No amount of topical dressing can compensate for a tissue oxygen deficit at the cellular level.

2. Peripheral Neuropathy

Nerve damage blunts pain perception, so patients walk on wounds without realizing it. Repeated mechanical stress re-injures healing tissue before it can consolidate. Neuropathy also impairs local vascular reflexes that normally direct blood flow toward a healing wound.

3. Impaired Immune Function

Hyperglycemia reduces the ability of neutrophils and macrophages — the white blood cells responsible for clearing infection and initiating repair — to function effectively. A Wagner Grade III ulcer with osteomyelitis requires both aggressive antimicrobial control and tissue-level immune support. Antibiotics address the bacteria. HBOT addresses the oxygen-depleted environment that allows bacteria to persist.

When tissue oxygen tension (tcPO2) falls below approximately 30 mmHg, the wound healing cascade stalls almost entirely. The body's fibroblasts need oxygen to synthesize collagen. The immune system needs oxygen to kill bacteria. New blood vessels need oxygen to grow. HBOT restores that oxygen supply directly.

How HBOT Heals Diabetic Wounds

During an HBOT session, a patient rests inside a monoplace hyperbaric chamber and breathes 100% medical-grade oxygen at pressures between 2.0 and 2.4 ATA (atmospheres absolute). At that pressure, oxygen does not simply bind to hemoglobin — it dissolves directly into blood plasma, cerebrospinal fluid, and interstitial fluid.

This hyperoxygenated plasma can reach tissues where red blood cells cannot, including the ischemic wound edges of a Grade III ulcer.

The Four-Phase Healing Response

Phase 1 (1 session): Tissue oxygen levels increase up to 10–15x baseline. ATP production surges. Acute edema and inflammatory signaling begin to resolve.

Phase 2 (around 10 sessions): VEGF (vascular endothelial growth factor) rises, triggering capillary budding. CD34+ stem cells are mobilized from bone marrow at up to 8x baseline levels and migrate toward the wound site. This is the angiogenesis phase — new blood vessel formation that restores long-term perfusion.

Phase 3 (20–30 sessions): Mature angiogenesis consolidates. Collagen synthesis accelerates. Fibroblasts lay down new extracellular matrix. The wound bed visibly granulates and contracts.

Phase 4 (30–40+ sessions): For osteomyelitis cases, HBOT enhances the oxygen-dependent killing mechanisms of white blood cells, working synergistically with systemic antibiotics. Bone repair and soft-tissue remodeling continue.

In addition to accelerating tissue repair, HBOT exerts a direct antimicrobial effect. Anaerobic bacteria — which drive deep wound infections — cannot survive in a high-oxygen environment. HBOT does not replace antibiotic therapy; it makes it more effective.

Clinical Evidence: What the Research Shows

The evidence base for hyperbaric oxygen therapy in diabetic foot ulcer treatment is among the strongest for any HBOT indication.

• Up to 4x higher wound healing rates with HBOT for diabetic foot ulcers compared to standard care alone (Marx & Johnson, Undersea and Hyperbaric Medical Society, 2019).
• A 2025 systematic review published in Cureus (Damineni et al., 2025) analyzed multiple controlled trials and confirmed that HBOT combined with standard wound care significantly improves wound closure outcomes and reduces the risk of major limb amputation compared to standard care alone. (PMC11890413)
• A 2025 retrospective case-control study (Benix et al., Cureus) at a tertiary care center confirmed that adjunct HBOT significantly accelerated healing timelines for diabetic foot ulcers when compared to standard wound care alone. (PMC12809191)
• The Undersea and Hyperbaric Medical Society (UHMS) Clinical Practice Guideline for HBOT in diabetic foot ulcers concluded with a Grade 1B recommendation — strong evidence — that HBOT reduces amputation rates in patients with ischemic, non-healing diabetic wounds.
• StatPearls / NCBI (2026) confirms that HBOT is a recommended adjunctive treatment for Wagner Grade III+ diabetic wounds, with strong mechanistic and clinical support.

The Centers for Medicare and Medicaid Services (CMS) concluded in its National Coverage Analysis that HBOT is "clinically effective and, thus, reasonable and necessary" for patients with limb-threatening diabetic wounds meeting Wagner Grade III criteria.

Medicare Coverage for HBOT: What You Need to Qualify

Medicare Part B covers hyperbaric oxygen therapy for diabetic foot ulcers under National Coverage Determination (NCD) 20.29, provided all three criteria are met:

Criterion 1: The patient has Type 1 or Type 2 diabetes and a lower extremity wound that is due to diabetes.

Criterion 2: The wound is classified as Wagner Grade III or higher.

Criterion 3: The patient has failed an adequate course of standard wound therapy — documented as at least 30 days of treatment without measurable signs of healing.

What Counts as "Standard Wound Therapy"?

Standard therapy that must be documented before HBOT approval includes: assessment and correction of vascular insufficiency, optimization of blood glucose control, debridement, moist wound dressings, off-loading of pressure, and treatment of wound infection. All interventions must be documented with clinical notes showing no measurable wound improvement during the 30-day window.

Cost Under Medicare

Medicare Part B typically covers 80% of the approved amount. Patients are responsible for the 20% co-insurance, and the Part B deductible may apply. Most PPO plans follow similar coverage logic for FDA-approved indications.

OxygenWell handles all insurance pre-authorization. Our billing team coordinates directly with Medicare and PPO insurers on behalf of patients so that coverage is confirmed before therapy begins. Verify your insurance coverage here.

What to Expect: HBOT Treatment Protocol

At OxygenWell, HBOT for diabetic foot ulcers follows evidence-based hyperbaric medicine protocols:

• Pressure: 2.0–2.4 ATA (medical-grade, FDA-rated chambers)
• Session duration: 90 minutes of oxygen breathing per session
• Frequency: 5 sessions per week (daily, Monday–Friday)
• Total sessions: Typically 30–40 sessions for Wagner Grade III; more for osteomyelitis or Grade IV cases
• Adjunct therapies: Photobiomodulation (Red Light Therapy) is available as a complementary modality to support circulation, reduce inflammation, and accelerate tissue repair between HBOT sessions

Each patient undergoes a medical evaluation before therapy begins. Dr. Beth Meneley and her clinical team review diagnosis, wound classification, vascular status, infection control, and blood glucose management to build a personalized protocol. A Safety Director with 12+ years of hyperbaric experience and EMT-certified technicians supervise every session.

Unlike many wound care centers where HBOT is an afterthought, at OxygenWell hyperbaric medicine is the entire clinical focus. Every protocol decision is made through the lens of 50,000+ supervised sessions and direct expertise in how oxygen dosing, pressure, and session sequencing affect wound outcomes.

Diabetic Wound Care in Los Angeles: Why OxygenWell

Most hyperbaric centers in Los Angeles operate at 1.3–1.5 ATA — far below the pressures required for Medicare-eligible wound care. OxygenWell's FDA-rated monoplace chambers are certified to 2.4 ATA, delivering the full therapeutic oxygen dose that clinical evidence supports for Wagner Grade III+ wounds.

California law requires hyperbaric facilities to be physician-owned — a critical safety and compliance standard that many centers do not meet. OxygenWell is physician-owned, physician-directed, and built specifically around hyperbaric and regenerative medicine.

Key Differentiators for Diabetic Wound Patients

• Medical-grade oxygen delivery: High-flow oxygen system, not a standard 10-liter concentrator
• Insurance-approved facility: Meets FDA, medical oversight, and safety requirements for Medicare/PPO coverage
• Grounded monoplace chambers: Maximum safety for medically complex patients
• On-site PA coverage: Physician Assistant present most weekday hours for clinical monitoring
• Evening and weekend hours: Rare among HBOT centers — critical for working patients and those managing complex medical schedules

OxygenWell serves patients across Sherman Oaks, Calabasas, Encino, Woodland Hills, Westlake Village, and the greater Los Angeles area.

If your wound has not healed after 30 days of standard care, you may already qualify. Call (818) 661-0939 or book a consultation online to speak with our team. Physician referrals are welcome — download our referral form.

Frequently Asked Questions

What is a Wagner Grade 3 diabetic wound?

A Wagner Grade 3 diabetic foot ulcer is a deep wound that has penetrated to bone, joint capsule, or tendon, typically with active infection (osteomyelitis or deep abscess). It is the minimum severity level that qualifies for Medicare-covered HBOT under NCD 20.29.

Does Medicare cover hyperbaric oxygen therapy for diabetic foot ulcers?

Yes. Medicare Part B covers HBOT for diabetic lower extremity wounds classified as Wagner Grade III or higher when the patient has failed at least 30 days of documented standard wound therapy. OxygenWell is a Medicare-approved HBOT facility and handles all pre-authorization.

How many HBOT sessions does it take to heal a diabetic foot ulcer?

Most Wagner Grade III protocols involve 30–40 sessions (approximately 6–8 weeks at 5 sessions per week). Some cases involving osteomyelitis or significant tissue loss require additional sessions. Progress is assessed regularly throughout treatment.

Why won't my diabetic foot ulcer heal with dressings and antibiotics alone?

Diabetic microangiopathy (small vessel damage) severely restricts blood flow to the wound, creating tissue oxygen deficits that block every step of the healing cascade — collagen synthesis, angiogenesis, immune activity. Antibiotics treat the infection but cannot restore the oxygen supply the tissue needs to regenerate. HBOT addresses the root physiological problem.

Is HBOT safe for people with diabetes?

Yes, for the vast majority of patients. HBOT is well-tolerated by diabetic patients. Blood glucose levels are monitored before each session, as HBOT can lower blood sugar. The main temporary side effects are mild ear discomfort (pressure equalization) and, in rare cases, temporary vision changes. Our medical team evaluates each patient thoroughly before beginning therapy.

Can HBOT prevent amputation?

HBOT cannot guarantee amputation prevention, but clinical evidence strongly supports its role in reducing amputation risk. The UHMS Clinical Practice Guideline gives HBOT a Grade 1B recommendation for reducing major amputation rates in ischemic, non-healing diabetic wounds. Early referral — before the wound progresses to Grade IV or V — improves outcomes significantly.

Does OxygenWell treat diabetic wound patients in Sherman Oaks and Calabasas?

Yes. OxygenWell operates hyperbaric clinics at both Sherman Oaks and Calabasas, CA. We accept Medicare and PPO insurance for diabetic foot ulcers meeting Wagner Grade III+ criteria. Call (818) 661-0939 or book online at oxygenwell.com.

Conclusion

A non-healing diabetic foot ulcer is not just a wound problem. It is a tissue oxygen problem — one that standard wound care alone cannot reliably solve at Wagner Grade III severity and beyond. Hyperbaric oxygen therapy addresses the physiological deficit directly, delivering oxygen to tissue that cannot receive it through normal circulation, triggering angiogenesis, enhancing immune function, and working synergistically with antibiotics to clear infection.

The evidence is strong. The Medicare pathway is clear. And for patients in Los Angeles, a physician-owned, insurance-approved HBOT facility with 50,000+ supervised sessions is available in Sherman Oaks and Calabasas.

Your next step does not have to wait another 30 days. If your wound qualifies today, our team at OxygenWell can verify your insurance coverage and initiate a pre-authorization within days.

Book a Consultation | Call (818) 661-0939 | Physician Referral Form

Dr. Beth Meneley, DAOM, L.Ac., is the founder of OxygenWell Hyperbaric & Regenerative Medicine Center. With 25+ years in integrative medicine, 12+ years dedicated to hyperbaric medicine in Los Angeles, and 50,000+ supervised HBOT sessions, she is one of the foremost hyperbaric medicine practitioners in Southern California.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before beginning any treatment program.